Partners
Diamond Partners
GSK
GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.
We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.
We prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology. For more information, please visit:
AstraZeneca
We are focused on creating genuinely innovative medicines and improving access to them. In this way, we deliver the greatest benefit to patients, healthcare systems and societies globally.
We have three priorities designed to deliver our growth through innovation strategy.
Accelerate Innovative Science:
Accelerating the next wave of new molecular entities, building our capabilities in immunology and rare diseases, pursuing new scientific modalities and driving R&D productivity
Deliver Growth and Therapy Area Leadership:
Meeting our growth and profitability goals through successful innovation and commercial excellence, as well as completing the Alexion acquisition
Be a Great Place to Work:
Contributing to the enterprise and to society, with a focus on inclusion and diversity, lifelong learning, improving access to healthcare, environmental protection, and ethics and transparency, as well as delivering our Ambition Zero Carbon program.
Inspired by our Values and what science can do, we are focused on accelerating the delivery of life-changing medicines that create enduring value for patients and society.
We are committed to operating in a way that recognizes the interconnection between business growth, the needs of society and the limitations of our planet. For more information, please visit:
Platinum Partner
Boehringer Ingelheim
Improving the health and lives of humans and animals is the goal of the research-driven biopharmaceutical company Boehringer Ingelheim. The focus is on diseases in areas with a high unmet medical need. The company therefore concentrates on developing innovative therapies that can improve and extend lives.
Family-owned since its foundation in 1885, Boehringer Ingelheim is one of the top 20 companies in the pharmaceutical industry. Our aim is to transform the lives of patients – across generations. This goal inspires all of our over 53,000 employees who create value through innovation.
Boehringer Ingelheim is active in the research areas of cardiometabolic diseases, oncology, respiratory diseases, immunology, diseases of the central nervous system and retinal health, The company spent some 5.0 billion euros on research and development worldwide in 2022, with research and development expenses on human pharma alone accounting for 24.8 percent of net sales generated in this area. The global research network for human pharmaceuticals includes facilities in Germany (Biberach and Ochsenhausen), the USA (Ridgefield), Austria (Vienna and Innsbruck), Japan (Kobe) and Switzerland (Basel and Geneva). To learn more, visit: https://www.boehringerone.com/sa/respiratory/ofev/ipf
Gold Partner
Pfizer
Pfizer is a research based global biopharmaceutical company that engaged in the discovery, development & manufacturing of healthcare products that includes medicines and vaccines to improve patient’s lives. It has been operating in Saudi Arabia since early 1960s. And it has a portfolio in different therapeutic areas include internal medicines, vaccines, oncology, inflammation & Immunology, rare diseases, hospital healthcare, cardiovascular that aim to provide high quality medicines, promoting health, raising awareness bar of various diseases and therapeutic areas, and providing a preventive solution in partnership with the local government and private healthcare institutions.
For more information, please visit: https://www.pfizersaudi.com.sa/en
Silver Partners
Hikma
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we are helping to shape a healthier world that enriches all our communities. We do this by living our culture, delivering our strategy, and acting responsibly.
We are a trusted, reliable partner and dependable source of over 760+ (as of 31 December 2022) high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe.
We are a global business with 32 manufacturing plants and 8 R&D centres. We are a global company with a local presence in KSA since 1998 and we are producing high quality medicines and making them accessible to the people who need them through our three specialised plants, the general formulation plant, penicillin plant and cephalosporin plant in Riyadh. To learn more, visit: https://www.hikma.com/home/
Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible.
We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. For more information, please visit: https://www.campus.sanofi
Contributors
ResMed
At ResMed, we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases.
Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. For more information, please visit: www.resmed.com
Sudair Pharmaceutical Company
Sudair Pharmaceutical Company (SPC) is a limited liability Saudi company, established in 2014 in order to build an “Advanced Pharmaceutical Industrial Complex” to fulfil the unmet in the pharmaceutical market with a Vision to improve lives through localizing advanced therapies by increasing the accessibility of high-quality medicinal products, building a professional team to localize and develop a cutting-edge manufacturing technologies.
Sudair Pharma started its mission in KSA & GCC market through building the 1st manufacturing facility in the region dedicated for anti-neoplastic agents (oral & IV) then we expanded our portfolio through building a dedicated site for specialized products that cover different therapy areas like Multiple Sclerosis, Neurology, Anti-coagulation & Pulmonary Hypertension in addition to a wide portfolio for Asthma and CODP management. For more information, please visit: https://sudairpharma.com/
Bayer
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. An analysis by well-known branding agency Interbrand in 2015 valued the Bayer brand at €6.3 billion. A growing and aging world population requires an adequate supply of food and improved medical care.
With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.
Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer. All this goes to make up our purpose: Science for a better life. For more information, please visit: www.bayer.com
NOVARTIS
NOVARTIS is a leading global pharmaceutical company reimagining medicine to improve people’s lives. We are committed to Saudi society to continue support national health care system with innovative medicines, improve patient access and contribute to National Transformation Plan and Saudi vision 2030.
Novartis worked out a comprehensive localization plan that addresses many economic as well as other transformation measures that go with the government plans like localization of work forces, technology transfers, R&D, support different national healthcare programs and access to innovation.
Novartis had chosen KSA to be one of the first group of worldwide markets to implement cell & gene technologies. For that, we are committed to work with our partners in Saudi Arabia who are among the best health care providers & centers to establish the infrastructure, human capabilities, regulatory environment and technology transfer of this era. Our effort up-to-date made an excellent achievement where on November 2019, the first injected patient of gene therapy outside EU and US was in Saudi Arabia. We are proud of making this for the first time because of collaboration and support of different Saudi government agencies and institutions. For more information, please visit: https://www.novartis.com/sa-ar/
Chiesi
Chiesi Farmaceutici is a research-focused international group with more than 87 years of experience and is headquartered in Parma (Italy). Chiesi research, develops and markets innovative drugs for respiratory treatment, special care and rare diseases.
We are among the top 50 pharmaceutical companies in the world. Our production activity takes place in 3 plants located in Parma (Italy), Blois (France) and Santana de Parnaiba (Brazil). The Group’s R&D Centre is based in Parma and works alongside 5 other important
research and development centres in France, the U.S., Canada, the UK and Sweden to promote its pre-clinical, clinical and regulatory programmes. The Group employs more than 6,000 people.
Chiesi is the largest global pharmaceutical group to be awarded B Corp Certification, a recognition of high social and environmental standards. It feels natural: caring for others is at the root of health science and it has always been at the core of our work. The Company is
also committed to becoming carbon neutral, generating zero impact on the environment, by the end of 2035. For more information, please visit: https://www.chiesi.com/en/
Johnson & Johnson
At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism & Retina; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension.
For more information, please visit: https://www.janssenmedicalcloud.com/en-us/
MSD
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world’s most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A.
Through our prescription medicines, vaccines, biologic therapies, and animal health products, we collaborate with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs, and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, emerging animal diseases, Alzheimer’s disease, and infectious diseases including HIV and Ebola.
MSD products have been present for over 30 years in the GCC region through its local distributors in the UAE, KSA, Kuwait, Bahrain, Qatar & Oman, and MSD ranks among the leading pharmaceutical companies in the region. MSD provides innovative medications in several therapeutic areas, including Anti-Infectives, Diabetes, HCV, HIV, Oncology, and Anesthesia in addition to several specialized Vaccines. For more information, please visit: www.msd.com
Exhibitors
Johnson & Johnson
At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 135 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most diversified healthcare products company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
Every day, our more than 150,000 employees across the world are blending heart, science and ingenuity to profoundly change the trajectory of health for humanity. To learn more, visit: https://www.jnjmedtech.com/en-EMEA
Baxter
Baxter touches the lives of millions of people around the world every day. Our products and therapies can be found throughout hospitals and clinics – from the ER to the OR, from the pharmacy to the ICU – as well as advancing patients’ care in their homes.
For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians and providers around the world. We believe every person regardless of who they are or where they are from deserves a chance to live a healthy life, free from illness and full of possibility. At the intersection of progress and purpose is where we are redefining what it means to be a global medtech leader. It is where we are relentlessly pursuing healthcare transformation, fueled by our compassion for patients and providers and the challenges they face. It is where bold ideas meet the promise for meaningful change in the world around us. We are there, at every step of the journey, to help clinicians deliver the best care possible. To learn more, visit: www.baxter.com
Medtronic
Bold thinking. Bolder actions. We are Medtronic.
Where we are
150+
Countries
80
Manufacturing sites
38
Labs and R&D sites
17
Distribution sites
We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. To learn more, visit: https://www.medtronic.com/me-en/index.html
Qomel
Qomel is healthcare provider company specialized in specific treatment areas: offering healthcare professionals with high quality products and services. among those areas: pulmonary hypertension. where we partnered with OHRE PHARMA (France) to supply top quality European medicines: including Sildenafil 20 mg for (pulmonary hypertension) and Bosentan 125 mg & 62.5. To learn more, visit:https://www.qomel.com/
Gulf Medical Company
Our Mission is to provide state of the art technology and solutions to the healthcare industry in Saudi Arabia and the GCC, and work closely with medical practitioners to contribute to patient care. To play an active role in developing skills of healthcare providers with the support of our suppliers. To evaluate market needs, adapt to changing demands, and continuously enrich our portfolio to effectively focus corporate assets in the service of various disciplines, thus enabling healthy growth. To continue our commitment to offer premium and unique services and ensure ultimate levels of customer satisfaction by recruiting, developing, motivating, and rewarding highly qualified personnel who demonstrate exceptional levels of professionalism and dedication. We believe that making a sale is not the end, but the beginning of a long-lasting relationship which is prized above all. For more information, please visit our website: www.gulfmedical.com
Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at: https://www.viatris.com/en and https://investor.viatris.com/events-and-presentations
Arabian Trade House
In today’s business landscape, the success of a company is largely determined by its capacity to innovate and improve in order to meet the ever-evolving needs of the market.
At Redax, we excel in combining experience and innovation to effectively address clinical requirements. Through continuous collaboration with physicians, engineers, and opinion leaders, we ensure that our products not only meet but surpass expectations. From the initial product prototype to the final marketing stage, we leave no room for chance.
Our Research and Development department has consistently delivered a wide range of drains and continues to offer innovative solutions, constantly enhancing our product catalog at Redax. With our extensive expertise in silicone molding and extrusion processes, we guarantee the highest quality for our silicone drainages available in the market.
We take pride in our internal production processes, which enable us to maintain control over all manufacturing stages. This ensures that we consistently deliver superior quality products, along with fast delivery and competitive costs. By overseeing the entire production process, we maintain a high level of quality control and can swiftly respond to customer demands.
At Redax, our commitment to innovation, collaboration, and quality allows us to meet the evolving needs of the market and provide our customers with superior products and services.
For more information, please visit our website: https://www.redax.it/en/
Anfas Group
Anfas Medical is a leading global company, established in the year 2007 and headquartered in the capital city of Riyadh. The core focus of Anfas Medical lies in the importation of critical intensive respiratory medical equipment, which is subsequently distributed to various medical institutions across Saudi Arabia. The company connected with more than 18 global companies in the domain of medical equipment and spare parts, facilitated through comprehensive distribution agreements. the biggest of them being Hamilton Medical of Switzerland and Ganshorn of Germany.
Furthermore, Anfas Medical has expanded its operations beyond the borders of Saudi Arabia, establishing branches in the United Arab Emirates, Jordan, and Bahrain, thereby fortifying its global presence and enhancing its reach in the healthcare sector. To learn more, Visit: www.anfasmedical.com
Vitalograph
Vitalograph is a global leading provider of respiratory diagnostic solutions. Through the delivery of solutions that are accurate and reliable, healthcare professionals are empowered to give the best possible respiratory care to their patients, wherever it is needed.
Vitalograph has recently launched VitaloPFT, its highly anticipated pulmonary function testing range, aimed for use in secondary care. The VitaloPFT series delivers advanced respiratory diagnostic solutions to hospitals and other secondary care units that demand complex pulmonary function testing. Renowned for its highly accurate and reliable spirometry solutions, Vitalograph’s latest addition embodies the company’s advanced respiratory diagnostics expertise and delivers versatility and value to healthcare providers. The addition of the VitaloPFT series means that Vitalograph is the manufacturer with the largest array of respiratory diagnostic solutions in the world.
All of Vitalograph’s respiratory diagnostic solutions are designed to be used with highly effective bacterial viral filters (BVF™), which keep cross-contamination to a minimum during testing, protecting both patient and healthcare provider. Vitalograph’s main R&D and manufacturing operations are located in its Irish base, in County Clare. To learn more, visit: https://vitalograph.com/
Supporters
Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 5.3 billion euros. For more information, please visit: www.bayer.com.
Immedica
Vision and values: Immedica’s vision is to become the leading and preferred Specialty Care Partner Company, launching and making niche specialty and rare disease medicines available to patients with high unmet medical need in Europe and the Middle East. Our core values are: Effective, Empowered, Open & Honest
Our story: Committed to our customers and benefit for patients Immedica has developed a well-tailored and efficient approach for the successful management of rare disease products, including orphan drugs.
In optimizing access to the products, we offer a package of complete commercial pharmaceutical services and strategies including marketing and sales via an experienced rare disease field force, navigation of the complex pricing and reimbursement….
For more information, please visit: www.immedica.com
Juniper Biologics
Juniper Biologics is a science-led specialty healthcare company headquartered in Singapore, focusing on commercializing novel therapies. Founded on a vision to provide life-changing treatments to cater to unmet needs, the company specialized in therapy areas that can make the most difference: oncology and oncology supportive care, rare/orphan diseases, and gene therapy. For more information, please visit: https://www.juniperbiologics.com
Merck
We are here for people at every step, helping to create, improve and prolong life. We deliver personalized treatments for serious diseases and enable people to achieve their dream of becoming parents. We empower the scientific community. Our tools, services and digital platform make research simpler, more exact, and help deliver breakthroughs more quickly. Our solutions accelerate access to health by assuring tests are accurate and the medicine we take can be trusted. We are the company behind the companies, advancing digital living. Our science sits inside technologies that are changing the way we access, store, process, and display information. Our innovations are unlocking the power and potential of data to open new possibilities to transform life on Earth as we know it.
We are making discoveries that can change the landscape of entire industries. For more than 350 years, we have been pushing the boundaries of what is possible, and we will continue to do so in the years to come. For more information, please visit: https://www.merckgroup.com/en
Biopharma-mea
At Biopharma-mea, our advanced strategy is to develop and enrich reliable and effective market access for multinational pharmaceutical companies to the Middle East markets, especially in the fields of pioneering biotech pharmaceutical products. We are the catalyst which allows them to successfully introduce their innovative therapies to the Middle Eastern medical landscape which seek to benefit the patients from the advancements in modern biotechnology that these therapies bring.
We strike at the core of serious diseases to change people’s lives. Bringing together the brightest minds, investing in science, and taking smart risks, we go all in. For the lives we have changed and for those who are still waiting, we will never stop fighting until we discover cures. For more information, please visit: www.biopharma-mea.com and www.vrtx.com
